TY - JOUR AU - Lipton, R. B. AU - Bigal, M. E. AU - Diamond, M. AU - Freitag, F. AU - Reed, M. L. AU - Stewart, W. F. PY - 2007 DA - 2007// TI - Migraine prevalence, disease burden, and the need for preventive therapy JO - Neurology VL - 68 UR - https://doi.org/10.1212/01.wnl.0000252808.97649.21 DO - 10.1212/01.wnl.0000252808.97649.21 ID - Lipton2007 ER - TY - JOUR AU - Lantéri-Minet, M. AU - Duru, G. AU - Mudge, M. AU - Cottrell, S. PY - 2011 DA - 2011// TI - Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review JO - Cephalalgia VL - 31 UR - https://doi.org/10.1177/0333102411398400 DO - 10.1177/0333102411398400 ID - Lantéri-Minet2011 ER - TY - JOUR AU - Mitsikostas, D. D. AU - Thomas, A. M. PY - 1999 DA - 1999// TI - Comorbidity of headache and depressive disorders JO - Cephalalgia VL - 19 UR - https://doi.org/10.1046/j.1468-2982.1999.019004211.x DO - 10.1046/j.1468-2982.1999.019004211.x ID - Mitsikostas1999 ER - TY - JOUR PY - 2013 DA - 2013// TI - The International Classification of Headache Disorders, 3rd edition (beta version) JO - Cephalalgia VL - 33 UR - https://doi.org/10.1177/0333102413485658 DO - 10.1177/0333102413485658 ID - ref4 ER - TY - JOUR AU - Lipton, R. B. AU - Silberstein, S. D. PY - 2015 DA - 2015// TI - Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention JO - Headache VL - 55 UR - https://doi.org/10.1111/head.12505_2 DO - 10.1111/head.12505_2 ID - Lipton2015 ER - TY - STD TI - Abu Bakar N, Tanprawate S, Lambru G, Torkamani M, Jahanshahi M, Matharu M. Quality of life in primary headache disorders: a review. Cephalalgia. 2015. [Epub ahead of print]. ID - ref6 ER - TY - JOUR AU - Erdélyi-Bótor, S. AU - Aradi, M. AU - Kamson, D. O. AU - Kovács, N. AU - Perlaki, G. AU - Orsi, G. PY - 2015 DA - 2015// TI - Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study JO - Headache VL - 55 UR - https://doi.org/10.1111/head.12459 DO - 10.1111/head.12459 ID - Erdélyi-Bótor2015 ER - TY - JOUR PY - 2015 DA - 2015// TI - Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 JO - Lancet VL - 386 UR - https://doi.org/10.1016/S0140-6736(15)60692-4 DO - 10.1016/S0140-6736(15)60692-4 ID - ref8 ER - TY - JOUR AU - Steiner, T. J. AU - Birbeck, G. L. AU - Jensen, R. H. AU - Katsarava, Z. AU - Stovner, L. J. AU - Martelletti, P. PY - 2015 DA - 2015// TI - Headache disorders are third cause of disability worldwide JO - J Headache Pain VL - 16 UR - https://doi.org/10.1186/s10194-015-0544-2 DO - 10.1186/s10194-015-0544-2 ID - Steiner2015 ER - TY - JOUR AU - Silberstein, S. D. AU - Holland, S. AU - Freitag, F. AU - Dodick, D. W. AU - Argoff, C. AU - Ashman, E. PY - 2012 DA - 2012// TI - Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society JO - Neurology VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182535d20 DO - 10.1212/WNL.0b013e3182535d20 ID - Silberstein2012 ER - TY - JOUR AU - Evers, S. AU - Afra, J. AU - Frese, A. AU - Goadsby, P. J. AU - Linde, M. AU - May, A. PY - 2009 DA - 2009// TI - EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force JO - Eur J Neurol VL - 16 UR - https://doi.org/10.1111/j.1468-1331.2009.02748.x DO - 10.1111/j.1468-1331.2009.02748.x ID - Evers2009 ER - TY - JOUR AU - Evers, S. AU - Jensen, R. PY - 2011 DA - 2011// TI - Treatment of medication overuse headache-guideline of the EFNS headache panel JO - Eur J Neurol VL - 18 UR - https://doi.org/10.1111/j.1468-1331.2011.03497.x DO - 10.1111/j.1468-1331.2011.03497.x ID - Evers2011 ER - TY - JOUR AU - Dodick, D. W. AU - Turkel, C. C. AU - DeGryse, R. E. AU - Aurora, S. K. AU - Silberstein, S. D. AU - Lipton, R. B. PY - 2010 DA - 2010// TI - OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program JO - Headache VL - 50 UR - https://doi.org/10.1111/j.1526-4610.2010.01678.x DO - 10.1111/j.1526-4610.2010.01678.x ID - Dodick2010 ER - TY - JOUR AU - Lipton, R. B. AU - Silberstein, S. AU - Dodick, D. AU - Cady, R. AU - Freitag, F. AU - Mathew, N. PY - 2011 DA - 2011// TI - Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study JO - Cephalalgia VL - 31 UR - https://doi.org/10.1177/0333102410372427 DO - 10.1177/0333102410372427 ID - Lipton2011 ER - TY - JOUR AU - Diener, H. C. AU - Bussone, G. AU - Oene, J. C. AU - Lahaye, M. AU - Schwalen, S. AU - Goadsby, P. J. PY - 2007 DA - 2007// TI - Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study JO - Cephalalgia VL - 27 UR - https://doi.org/10.1111/j.1468-2982.2007.01326.x DO - 10.1111/j.1468-2982.2007.01326.x ID - Diener2007 ER - TY - JOUR AU - Grazzi, L. AU - Andrasik, F. PY - 2010 DA - 2010// TI - Non-pharmacological approaches in migraine prophylaxis: behavioral medicine JO - Neurol Sci VL - 31 UR - https://doi.org/10.1007/s10072-010-0306-5 DO - 10.1007/s10072-010-0306-5 ID - Grazzi2010 ER - TY - JOUR AU - Linde, M. AU - Mulleners, W. M. AU - Chronicle, E. P. AU - McCrory, D. C. PY - 2013 DA - 2013// TI - Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults JO - Cochrane Database Syst Rev VL - 6 ID - Linde2013 ER - TY - JOUR AU - Linde, M. AU - Mulleners, W. M. AU - Chronicle, E. P. AU - McCrory, D. C. PY - 2013 DA - 2013// TI - Topiramate for the prophylaxis of episodic migraine in adults JO - Cochrane Database Syst Rev VL - 6 ID - Linde2013 ER - TY - JOUR AU - Luykx, J. AU - Mason, M. AU - Ferrari, M. D. AU - Carpay, J. PY - 2009 DA - 2009// TI - Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine JO - Clin Pharmacol Ther VL - 85 UR - https://doi.org/10.1038/clpt.2008.203 DO - 10.1038/clpt.2008.203 ID - Luykx2009 ER - TY - JOUR AU - Gracia-Naya, M. AU - Santos-Lasaosa, S. AU - Ríos-Gómez, C. AU - Sánchez-Valiente, S. AU - García-Gomara, M. J. AU - Latorre-Jiménez, A. M. PY - 2011 DA - 2011// TI - Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine JO - Rev Neurol VL - 53 ID - Gracia-Naya2011 ER - TY - JOUR AU - Mitsikostas, D. D. AU - Mantonakis, L. I. AU - Chalarakis, N. G. PY - 2011 DA - 2011// TI - Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches JO - Cephalalgia VL - 31 UR - https://doi.org/10.1177/0333102410391485 DO - 10.1177/0333102410391485 ID - Mitsikostas2011 ER - TY - JOUR AU - Mitsikostas, D. D. PY - 2012 DA - 2012// TI - Nocebo in headaches: implications for clinical practice and trial design JO - Curr Neurol Neurosci Rep VL - 12 UR - https://doi.org/10.1007/s11910-011-0245-4 DO - 10.1007/s11910-011-0245-4 ID - Mitsikostas2012 ER - TY - JOUR AU - Hepp, Z. AU - Dodick, D. W. AU - Varon, S. F. AU - Gillard, P. AU - Hansen, R. N. AU - Devine, E. B. PY - 2015 DA - 2015// TI - Adherence to oral migraine-preventive medications among patients with chronic migraine JO - Cephalalgia VL - 35 UR - https://doi.org/10.1177/0333102414547138 DO - 10.1177/0333102414547138 ID - Hepp2015 ER - TY - JOUR AU - Karsan, N. AU - Goadsby, P. J. PY - 2015 DA - 2015// TI - CGRP mechanism antagonists and migraine management JO - Curr Neurol Neurosci Rep VL - 15 UR - https://doi.org/10.1007/s11910-015-0547-z DO - 10.1007/s11910-015-0547-z ID - Karsan2015 ER - TY - JOUR AU - Zeller, J. AU - Poulsen, K. T. AU - Sutton, J. E. AU - Abdiche, Y. N. AU - Collier, S. AU - Chopra, R. PY - 2008 DA - 2008// TI - CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat JO - Br J Pharmacol VL - 155 UR - https://doi.org/10.1038/bjp.2008.334 DO - 10.1038/bjp.2008.334 ID - Zeller2008 ER - TY - JOUR AU - Juhl, L. AU - Edvinsson, L. AU - Olesen, J. AU - Jansen-Olesen, I. PY - 2007 DA - 2007// TI - Effect of two novel CGRP-binding compounds in a closed cranial window rat model JO - Eur J Pharmacol VL - 567 UR - https://doi.org/10.1016/j.ejphar.2007.04.004 DO - 10.1016/j.ejphar.2007.04.004 ID - Juhl2007 ER - TY - JOUR AU - Walter, S. AU - Alibhoy, A. AU - Escandon, R. AU - Bigal, M. E. PY - 2014 DA - 2014// TI - Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide JO - MAbs VL - 6 UR - https://doi.org/10.4161/mabs.29242 DO - 10.4161/mabs.29242 ID - Walter2014 ER - TY - JOUR AU - Bigal, M. E. AU - Walter, S. AU - Rapoport, A. M. PY - 2013 DA - 2013// TI - Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development JO - Headache VL - 53 UR - https://doi.org/10.1111/head.12179 DO - 10.1111/head.12179 ID - Bigal2013 ER - TY - JOUR AU - Descotes, J. PY - 2009 DA - 2009// TI - Immunotoxicity of monoclonal antibodies JO - MAbs VL - 1 UR - https://doi.org/10.4161/mabs.1.2.7909 DO - 10.4161/mabs.1.2.7909 ID - Descotes2009 ER - TY - JOUR AU - Bigal, M. E. AU - Walter, S. AU - Bronson, M. AU - Alibhoy, A. AU - Escandon, R. PY - 2014 DA - 2014// TI - Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP JO - Cephalalgia VL - 34 UR - https://doi.org/10.1177/0333102414527646 DO - 10.1177/0333102414527646 ID - Bigal2014 ER - TY - JOUR AU - Bigal, M. E. AU - Escandon, R. AU - Bronson, M. AU - Walter, S. AU - Sudworth, M. AU - Huggins, J. P. PY - 2013 DA - 2013// TI - Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: results of the Phase 1 program JO - Cephalalgia VL - 34 UR - https://doi.org/10.1177/0333102413517775 DO - 10.1177/0333102413517775 ID - Bigal2013 ER - TY - JOUR AU - Dodick, D. W. AU - Goadsby, P. J. AU - Silberstein, S. D. AU - Lipton, R. B. AU - Olesen, J. AU - Ashina, M. PY - 2014 DA - 2014// TI - Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomized, double-blind, placebo-controlled, exploratory phase 2 trial JO - Lancet Neurol VL - 13 UR - https://doi.org/10.1016/S1474-4422(14)70209-1 DO - 10.1016/S1474-4422(14)70209-1 ID - Dodick2014 ER - TY - JOUR AU - Dodick, D. W. AU - Goadsby, P. J. AU - Spierings, E. L. AU - Scherer, J. C. AU - Sweeney, S. P. AU - Grayzel, D. S. PY - 2014 DA - 2014// TI - Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study JO - Lancet Neurol VL - 13 UR - https://doi.org/10.1016/S1474-4422(14)70128-0 DO - 10.1016/S1474-4422(14)70128-0 ID - Dodick2014 ER - TY - BOOK AU - Lenz, R. AU - Silberstein, S. AU - Dodick, D. AU - Reuter, U. AU - Ashina, M. AU - Saper, J. PY - 2015 DA - 2015// TI - Results of a randomized, double-blind, placebo-controlled, phase 2 study to evaluate the efficacy and safety of AMG 334 for the prevention of episodic migraine PB - 17th Congress of the International Headache Society CY - Valencia ID - Lenz2015 ER - TY - JOUR AU - Bigal, M. E. AU - Dodick, D. W. AU - Rapoport, A. M. AU - Silberstein, S. D. AU - Ma, Y. AU - Yang, R. PY - 2015 DA - 2015// TI - Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study JO - Lancet Neurol VL - 14 UR - https://doi.org/10.1016/S1474-4422(15)00249-5 DO - 10.1016/S1474-4422(15)00249-5 ID - Bigal2015 ER - TY - JOUR AU - Bigal, M. E. AU - Edvinsson, L. AU - Rapoport, A. M. AU - Lipton, R. B. AU - Spierings, E. L. AU - Diener, H. C. PY - 2015 DA - 2015// TI - Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study JO - Lancet Neurol VL - 14 UR - https://doi.org/10.1016/S1474-4422(15)00245-8 DO - 10.1016/S1474-4422(15)00245-8 ID - Bigal2015 ER - TY - JOUR AU - Shamliyan, T. A. AU - Choi, J. Y. AU - Ramakrishnan, R. AU - Miller, J. B. AU - Wang, S. Y. AU - Taylor, F. R. PY - 2013 DA - 2013// TI - Preventive pharmacologic treatments for episodic migraine in adults JO - J Gen Intern Med VL - 28 UR - https://doi.org/10.1007/s11606-013-2433-1 DO - 10.1007/s11606-013-2433-1 ID - Shamliyan2013 ER - TY - JOUR AU - Bertolotto, A. PY - 2015 DA - 2015// TI - Evaluation of the impact of neutralizing antibodies on IFNβ response JO - Clin Chim Acta VL - 449 UR - https://doi.org/10.1016/j.cca.2015.02.043 DO - 10.1016/j.cca.2015.02.043 ID - Bertolotto2015 ER - TY - JOUR AU - Seng, E. K. AU - Rains, J. A. AU - Nicholson, R. A. AU - Lipton, R. B. PY - 2015 DA - 2015// TI - Improving medication adherence in migraine treatment JO - Curr Pain Headache Rep VL - 19 UR - https://doi.org/10.1007/s11916-015-0498-8 DO - 10.1007/s11916-015-0498-8 ID - Seng2015 ER - TY - JOUR AU - Berger, A. AU - Bloudek, L. M. AU - Varon, S. F. AU - Oster, G. PY - 2012 DA - 2012// TI - Adherence with migraine prophylaxis in clinical practice JO - Pain Pract VL - 12 UR - https://doi.org/10.1111/j.1533-2500.2012.00530.x DO - 10.1111/j.1533-2500.2012.00530.x ID - Berger2012 ER - TY - STD TI - Ho TW, Ho AP, Ge YJ, Assaid C, Gottwald R, MacGregor EA, et al. Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine. Cephalalgia. 2015. [Epub ahead of print]. ID - ref41 ER - TY - JOUR AU - Ho, T. W. AU - Connor, K. M. AU - Zhang, Y. AU - Pearlman, E. AU - Koppenhaver, J. AU - Fan, X. PY - 2014 DA - 2014// TI - Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention JO - Neurology VL - 83 UR - https://doi.org/10.1212/WNL.0000000000000771 DO - 10.1212/WNL.0000000000000771 ID - Ho2014 ER - TY - JOUR AU - Deer, T. R. AU - Mekhail, N. AU - Petersen, E. AU - Krames, E. AU - Staats, P. AU - Pope, J. PY - 2014 DA - 2014// TI - The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee JO - Neuromodulation VL - 17 UR - https://doi.org/10.1111/ner.12215 DO - 10.1111/ner.12215 ID - Deer2014 ER - TY - STD TI - Ambrosini A, D'Alessio C2, Magis D, Schoenen J. Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives. Cephalalgia. 2015. [Epub ahead of print]. ID - ref44 ER - TY - JOUR AU - Schoenen, J. AU - Vandersmissen, B. AU - Jeangette, S. AU - Herroelen, L. AU - Vandenheede, M. AU - Gérard, P. PY - 2013 DA - 2013// TI - Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial JO - Neurology VL - 80 UR - https://doi.org/10.1212/WNL.0b013e3182825055 DO - 10.1212/WNL.0b013e3182825055 ID - Schoenen2013 ER - TY - JOUR AU - Magis, D. AU - Sava, S. AU - d’Elia, T. S. AU - Baschi, R. AU - Schoenen, J. PY - 2013 DA - 2013// TI - Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly device in headache treatment: A survey of 2,313 headache sufferers in the general population JO - J Headache Pain VL - 14 UR - https://doi.org/10.1186/1129-2377-14-95 DO - 10.1186/1129-2377-14-95 ID - Magis2013 ER - TY - JOUR AU - Russo, A. AU - Tessitore, A. AU - Conte, F. AU - Marcuccio, L. AU - Giordano, A. AU - Tedeschi, G. PY - 2015 DA - 2015// TI - Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience JO - J Headache Pain VL - 16 UR - https://doi.org/10.1186/s10194-015-0551-3 DO - 10.1186/s10194-015-0551-3 ID - Russo2015 ER - TY - BOOK AU - Silberstein, S. D. AU - Neves da Silva, A. AU - Calhoun, A. H. AU - Grosberg, B. M. AU - Lipton, R. B. AU - Cady, R. K. PY - 2014 DA - 2014// TI - Non-invasive vagus nerve stimulation for chronic migraine prevention in a prospective, randomized, sham-controlled pilot study (the EVENT study): report from the double-blind phase. Late breaking poster 19 PB - 56th Annual Scientific Meeting of the American Headache Society CY - Los Angeles, CA ID - Silberstein2014 ER - TY - BOOK AU - Silberstein, S. D. AU - Neves da Silva, A. AU - Calhoun, A. H. AU - Grosberg, B. M. AU - Lipton, R. B. AU - Cady, R. K. PY - 2014 DA - 2014// TI - Chronic migraine prevention with non-invasive vagus nerve stimulation in a prospective pilot study (the EVENT study): report from the open-label phase. Late breaking poster 21 PB - 56th Annual Scientific Meeting of the American Headache Society CY - Los Angeles, CA ID - Silberstein2014 ER - TY - JOUR AU - Nesbitt, A. D. AU - Marin, J. C. AU - Tompkins, E. AU - Ruttledge, M. H. AU - Goadsby, P. J. PY - 2015 DA - 2015// TI - Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment JO - Neurology VL - 84 UR - https://doi.org/10.1212/WNL.0000000000001394 DO - 10.1212/WNL.0000000000001394 ID - Nesbitt2015 ER - TY - STD TI - Gaul C, Diener HC, Silver N, Magis D, Reuter U, Andersson A, et al. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia. 2015. [Epub ahead of print]. ID - ref51 ER - TY - JOUR AU - Schoenen, J. AU - Jensen, R. H. AU - Lantéri-Minet, M. AU - Láinez, M. J. AU - Gaul, C. AU - Goodman, A. M. PY - 2013 DA - 2013// TI - Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study JO - Cephalalgia VL - 33 UR - https://doi.org/10.1177/0333102412473667 DO - 10.1177/0333102412473667 ID - Schoenen2013 ER - TY - JOUR AU - Misra, U. K. AU - Kalita, J. AU - Bhoi, S. K. PY - 2013 DA - 2013// TI - High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study JO - J Neurol VL - 260 UR - https://doi.org/10.1007/s00415-013-7072-2 DO - 10.1007/s00415-013-7072-2 ID - Misra2013 ER -